Vident Investment Advisory, LLC I Mab Transaction History

Vident Investment Advisory, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.95 - $3.85 $29,901 - $39,023	-10,136 Reduced 48.66%	10,693 $31,000
Q1 2023 May 15, 2023	BUY	$3.08 - $7.39 $26,180 - $62,815	8,500 Added 68.94%	20,829 $72,000
Q4 2022 Feb 14, 2023	SELL	$3.22 - $4.86 $198,123 - $299,030	-61,529 Reduced 83.31%	12,329 $51,000
Q3 2022 Nov 14, 2022	SELL	$4.01 - $12.34 $12,439 - $38,278	-3,102 Reduced 4.03%	73,858 $287,000
Q2 2022 Aug 15, 2022	BUY	$8.27 - $18.43 $399,920 - $891,237	48,358 Added 169.07%	76,960 $867,000

Q1 2022 May 16, 2022	BUY	$12.54 - $46.93 $82,864 - $310,113	6,608 Added 30.04%	28,602 $464,000
Q4 2021 Feb 14, 2022	SELL	$45.28 - $74.5 $48,540 - $79,864	-1,072 Reduced 4.65%	21,994 $1.04 Million
Q3 2021 Nov 12, 2021	SELL	$57.18 - $84.43 $142,263 - $210,061	-2,488 Reduced 9.74%	23,066 $1.67 Million
Q2 2021 Aug 13, 2021	SELL	$47.86 - $83.95 $1.09 Million - $1.91 Million	-22,793 Reduced 47.14%	25,554 $2.15 Million
Q1 2021 May 14, 2021	SELL	$44.38 - $63.97 $186,529 - $268,865	-4,203 Reduced 8.0%	48,347 $2.34 Million
Q4 2020 Feb 08, 2021	BUY	$32.94 - $47.15 $1.45 Million - $2.08 Million	44,059 Added 518.89%	52,550 $2.48 Million
Q3 2020 Nov 12, 2020	SELL	$27.46 - $47.03 $192,906 - $330,385	-7,025 Reduced 45.28%	8,491 $399,000
Q2 2020 Jul 17, 2020	SELL	$13.0 - $31.0 $55,978 - $133,486	-4,306 Reduced 21.72%	15,516 $464,000
Q1 2020 May 12, 2020	BUY	$10.63 - $15.37 $210,707 - $304,664	19,822 New	19,822 $258,000

16M

11.9K

3.5K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $130M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.